IMPLANTATION BY ELECTROPHYSIOLOGISTS OF 100 CONSECUTIVE CARDIOVERTER-DEFIBRILLATORS WITH NONTHORACOTOMY LEAD SYSTEMS

被引:62
作者
STRICKBERGER, SA
HUMMEL, JD
DAOUD, E
NIEBAUER, M
WILLIAMSON, BD
MAN, KC
HORWOOD, L
SCHMITTOU, A
KALBFLEISCH, SJ
LANGBERG, JJ
MORADY, F
机构
[1] Implantable Cardioverter D., Division of Cardiology, Univ. of Michigan Medical Center, Ann Arbor, MI
[2] Univ. of Michigan Medical Center, Ann Arbor, MI 48109-0022
关键词
DEFIBRILLATION; VENTRICULAR TACHYCARDIA; VENTRICULAR FIBRILLATION;
D O I
10.1161/01.CIR.90.2.868
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Traditional lead systems for implantable cardioverter defibrillators (ICDs) require a thoracotomy for placement. Nonthoracotomy lead systems are available and are usually implanted by an electrophysiologist and a surgeon. The purpose of this study was to prospectively evaluate the safety and efficacy of ICD implantation with a nonthoracotomy lead system by electrophysiologists. Methods and Results A consecutive series of 100 patients (mean age, 61+/-13 years, +/-SD) underwent ICD implantation with a nonthoracotomy lead system while intubated and under general anesthesia. Seventy-seven patients had coronary artery disease, 15 had idiopathic cardiomyopathy, 6 had miscellaneous heart disease, and 2 had structurally normal hearts. The mean ejection fraction was 0.29+/-0.13. Sixty-eight patients had suffered a cardiac arrest, and 32 had had ventricular tachycardia or syncope. All patients except 9 underwent electrophysiological testing and had failed 1+/-1 drug trials before ICD implantation. Three types of nonthoracotomy lead systems were used. The nonthoracotomy lead with an ICD was successfully implanted in 96 patients (96%). Of the unsuccessful implants, 1 patient did not have venous access, the passive fixation lead in 1 would not remain lodged, 1 had elevated defibrillation thresholds, and 1 developed a hemopneumothorax while venous access was being obtained. The mean defibrillation threshold was 17+/-6 J. The mean procedure duration was 161+/-57 minutes. When a subcutaneous patch was used (n=58), the procedure duration was 189+/-5 minutes, and when a subcutaneous patch was not required (n=40), the procedure lasted 123+/-37 minutes (P<.0001). Patients remained in the hospital 4.5+/-4.1 days after implantation, with no procedure-related deaths. Acute complications occurred in 10 patients; 2 had lead dislodgments, 1 with previous abdominal surgery had his abdominal cavity entered (without other complications) while the ICD pocket was being made, 1 had postoperative heart failure, 1 developed a large hematoma when anticoagulation therapy was initiated, 3 required reintubation because of excessive anesthesia, 1 developed superficial cellulitis, and 1 developed a hemopneumothorax secondary to a lacerated subclavian vein. During 6+/-3 months of follow-up, 2 patients developed lead fractures. Conclusions (1) Electrophysiologists can implant an ICD with a nonthoracotomy lead system safely and with a high success rate; (2) use of a subcutaneous patch correlates with longer procedure durations; and (3) special precautions should be taken in patients with previous abdominal surgery.
引用
收藏
页码:868 / 872
页数:5
相关论文
共 25 条
[1]   INTERMITTENT OVERSENSING DUE TO INTERNAL INSULATION DAMAGE OF TEMPERATURE SENSING RATE RESPONSIVE PACEMAKER LEAD IN SUBCLAVIAN VENIPUNCTURE METHOD [J].
ARAKAWA, M ;
KAMBARA, K ;
ITO, H ;
HIRAKAWA, S ;
UMEDA, S ;
HIROSE, H .
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 1989, 12 (08) :1312-1316
[2]   IMPLANTABLE TRANSVENOUS CARDIOVERTER-DEFIBRILLATORS [J].
BARDY, GH ;
HOFER, B ;
JOHNSON, G ;
KUDENCHUK, PJ ;
POOLE, JE ;
DOLACK, GL ;
GLEVA, M ;
MITCHELL, R ;
KELSO, D .
CIRCULATION, 1993, 87 (04) :1152-1168
[3]   CATHETER ABLATION OF VENTRICULAR-TACHYCARDIA USING DEFIBRILLATOR PULSES - ELECTROPHYSIOLOGICAL FINDINGS AND LONG-TERM RESULTS [J].
BORGGREFE, M ;
BREITHARDT, G ;
PODCZECK, A ;
ROHNER, D ;
BUDDE, T ;
MARTINEZRUBIO, A .
EUROPEAN HEART JOURNAL, 1989, 10 (07) :591-601
[4]   DETERMINANTS OF SUCCESSFUL NONTHORACOTOMY CARDIOVERTER-DEFIBRILLATOR IMPLANTATION - EXPERIENCE IN 101 PATIENTS USING 2 DIFFERENT LEAD SYSTEMS [J].
BROOKS, R ;
GARAN, H ;
TORCHIANA, D ;
VLAHAKES, GJ ;
JACKSON, G ;
NEWELL, J ;
MCGOVERN, BA ;
RUSKIN, JN .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1993, 22 (07) :1835-1842
[5]  
COX JL, 1989, CIRCULATION, V79, P163
[6]   CLINICAL-EXPERIENCE, COMPLICATIONS, AND SURVIVAL IN 70 PATIENTS WITH THE AUTOMATIC IMPLANTABLE CARDIOVERTER DEFIBRILLATOR [J].
ECHT, DS ;
ARMSTRONG, K ;
SCHMIDT, P ;
OYER, PE ;
STINSON, EB ;
WINKLE, RA .
CIRCULATION, 1985, 71 (02) :289-296
[7]   SUBCLAVIAN PUNCTURE FOR PACEMAKER LEAD PLACEMENT [J].
FURMAN, S .
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 1986, 9 (04) :467-467
[8]  
GARTMAN DM, 1990, J THORAC CARDIOV SUR, V100, P353
[9]   SURGICAL ABLATION OF VENTRICULAR-TACHYCARDIA WITH SEQUENTIAL MAP-GUIDED SUBENDOCARDIAL RESECTION - ELECTROPHYSIOLOGIC ASSESSMENT AND LONG-TERM FOLLOW-UP [J].
HAINES, DE ;
LERMAN, BB ;
KRON, IL ;
DIMARCO, JP .
CIRCULATION, 1988, 77 (01) :131-141
[10]   SURGICAL ENDOCARDIAL RESECTION FOR THE TREATMENT OF MALIGNANT VENTRICULAR TACHYCARDIA [J].
HARKEN, AH ;
JOSEPHSON, ME ;
HOROWITZ, LN .
ANNALS OF SURGERY, 1979, 190 (04) :456-460